当前位置: X-MOL 学术J. Am. Coll. Cardiol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Interventions for Congenital Atrioventricular Valve Dysfunction
Journal of the American College of Cardiology ( IF 24.0 ) Pub Date : 2022-05-30 , DOI: 10.1016/j.jacc.2021.08.083
Oliver M Barry 1 , Ismail Bouhout 2 , Susheel K Kodali 3 , Isaac George 4 , Marlon S Rosenbaum 3 , Christopher J Petit 1 , David Kalfa 2
Affiliation  

Innovation and creativity have led to tremendous advancements in the care and management of patients with congenital heart disease (CHD) that have resulted in considerably increased survival. Catheter-based interventions have contributed significantly to these advancements. However, catheter-based interventions for congenital lesions of the atrioventricular (AV) valves have been limited in scope and effectiveness mainly because of patient size and anatomical challenges. Thus, surgical repair and replacement for congenital AV valve lesions have remained the preferred therapy. However, the ongoing transcatheter heart valve revolution has led to techniques and technologies that are changing the landscape, particularly for adult CHD patients. Many devices for AV valve repair and replacement are being studied in adult patients without CHD, and translation of select practices to CHD patients has begun, with many more to come. Transcatheter AV valve interventions represent exciting opportunities for the growing numbers of adult CHD patients.



中文翻译:

先天性房室瓣功能障碍的干预措施

创新和创造力使先天性心脏病 (CHD) 患者的护理和管理取得了巨大进步,从而大大提高了生存率。基于导管的干预对这些进步做出了重大贡献。然而,基于导管的先天性房室 (AV) 瓣病变干预在范围和有效性方面受到限制,主要是因为患者体型和解剖学挑战。因此,先天性 AV 瓣膜病变的手术修复和置换仍然是首选疗法。然而,正在进行的经导管心脏瓣膜革命导致技术和技术正在改变格局,特别是对于成人 CHD 患者。许多用于 AV 瓣膜修复和置换的设备正在研究用于无冠心病的成年患者,并且已经开始向 CHD 患者翻译精选的实践,未来还会有更多。经导管 AV 瓣膜干预为越来越多的成年 CHD 患者提供了令人兴奋的机会。

更新日期:2022-05-31
down
wechat
bug